Hepatitis B or C viral infection and risk of pancreatic cancer: A meta-analysis of observational studies

World Journal of Gastroenterology

Volumn 19, Issue 26, 2013, Pages 4234-4241

  Xu, Jian Hua ^a,b,c   Fu, Jin Jian ^a,d   Wang, Xiao Li ^b   Zhu, Jia Yong ^b   Ye, Xiao Hua ^b   Chen, Si Dong ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^d Maternal and Child Care Service Hospital of Liuzhou   (China)

Author keywords

Hepatitis B; Hepatitis C; Meta analysis; Observational studies; Pancreatic cancer

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; META ANALYSIS; PANCREAS CANCER; PREVALENCE; TREATMENT OUTCOME; VIRUS CARRIER; VIRUS LOAD;

EID: 84880983940     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i26.4234     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int 2010; 30: 423-429 [PMID: 19840258 DOI: 10.1111/ j.1478-3231]
3. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology 2009; 49: 116-123 [PMID: 19085911 DOI: 10.1002/hep.22606]
4. Dehesa-Violante M, Nuñez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007; 38: 606-611 [PMID: 17613351]
5. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107 [PMID: 14996343]
6. World Health Organization. Hepatitis B. Fact sheet no. 2012, 204. Available from: URL: http//www.who.int/mediacentre/ factsheets/fs204/en
7. Hoefs JC, Renner IG, Askhcavai M, Redeker AG. Hepatitis B surface antigen in pancreatic and biliary secretions. Gastroenterology 1980; 79: 191-194 [PMID: 7399225]
8. Chen MY, Huang ZQ, Chen LZ, Gao YB, Peng RY, Wang DW. Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance. World J Gastroenterol 2000; 6: 800-804 [PMID: 11819699]
9. Berrington de Gonzalez A, Yun JE, Lee SY, Klein AP, Jee SH. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 2008; 17: 359-364 [PMID: 18268120 DOI: 10.1158/1055-9965.EPI-07-0507]
10. Hong SG, Kim JH, Lee YS, Yoon E, Lee HJ, Hwang JK, Jung ES, Joo MK, Jung YK, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. [The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study]. Korean J Hepatol 2010; 16: 49-56 [PMID: 20375642 DOI: 10.3350/kjhep.2010.16.1.49]
11. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M, Abbruzzese JL. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 2008; 26: 4557-4562 [PMID: 18824707 DOI: 10.1200/JCO.2008.17.3526]
12. Ben Q, Li Z, Liu C, Cai Q, Yuan Y, Wang K, Xiao L, Gao J, Zhang H. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China. Pancreas 2012; 41: 435-440 [PMID: 22422136 DOI: 10.1097/ MPA.0b013e31822ca176]
13. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Health Research Institute. Available from: URL: http//www.ohri.ca/programs/clinical_epidemiology/oxford. asp
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188 [PMID: 3802833]
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558 [PMID: 12111919]
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634 [PMID: 9310563]
17. Zhu F, Li HR, Du GN, Chen JH, Cai SR. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev 2011; 12: 1405-1408 [PMID: 22126472]
18. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer 2012; 131: 461-468 [PMID: 21858814 DOI: 10.1002/ ijc.26376]
19. Wang DS, Wang ZQ, Zhang L, Qiu MZ, Luo HY, Ren C, Zhang DS, Wang FH, Li YH, Xu RH. Are risk factors associated with outcomes in pancreatic cancer? PLoS One 2012; 7: e41984 [PMID: 22911869 DOI: 10.1371/journal. pone.0041984]
20. Iloeje UH, Yang HI, Chen CJ. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int 2012; 32: 1333-1341 [PMID: 22510145]
21. Sherman M. Pancreatic cancer in chronic hepatitis B. Liver Int 2010; 30: 339-341 [PMID: 20456036 DOI: 10.1111/ j.1478-3231.2009.02202.x]
22. de Gonzalez AB, Jee SH, Engels EA. No association between hepatitis B and pancreatic cancer in a prospective study in Korea. J Clin Oncol 2009; 27: 648; author reply 648-649 [PMID: 19103724 DOI: 10.1200/JCO.2008.20.7514]
23. Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, Costanzo M, Fricia T, Rampello E, Romano M. Hepatitis C virus in elderly cancer patients. Eur J Intern Med 2006; 17: 325-329 [PMID: 16864006]
24. Katakura Y, Yotsuyanagi H, Hashizume K, Okuse C, Okuse N, Nishikawa K, Suzuki M, Iino S, Itoh F. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol 2005; 11: 3508-3513 [PMID: 15962364]
25. Yoffe B, Bagri AS, Tran T, Dural AT, Shtenberg KM, Khaoustov VI. Hyperlipasemia associated with hepatitis C virus. Dig Dis Sci 2003; 48: 1648-1653 [PMID: 12924663]
26. Heinemann V, Haas M, Boeck S. Systemic treatment of advanced pancreatic cancer. Cancer Treat Rev 2012; 38: 843-853 [PMID: 22226241 DOI: 10.1016/j.ctrv.2011.12.004]
27. Hohenberger P. Detection of HBs-Ag in the pancreas in cases of pancreatic carcinoma. Hepatogastroenterology 1984; 31: 239-241 [PMID: 6510882]
28. Alvares-Da-Silva MR, Francisconi CF, Waechter FL. Acute hepatitis C complicated by pancreatitis: another extrahepatic manifestation of hepatitis C virus? J Viral Hepat 2000; 7: 84-86 [PMID: 10718948]
29. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 1984; 65 (Pt 3): 651-655 [PMID: 6699625]
30. Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, Yang DL, Hao LJ. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6: 805-811 [PMID: 11819700]
31. Mason A, Wick M, White H, Perrillo R. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 1993; 18: 781-789 [PMID: 8406351]
32. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998; 28: 1398-1401 [PMID: 9794927]
33. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980; 286: 533-535 [PMID: 6250074]
34. Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Chili E, Del Prete P, Bacchi-Reggiani L, Cuppini A, Jovine E. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma. Med Hypotheses 2012; 79: 678-697 [PMID: 22959312 DOI: 10.1016/ j.mehy.2012.08.008]